Initial Experience With Peptide Receptor Radionuclide Therapy (PRRT) for the Treatment of Neuroendocrine Tumors (NETS) at a Tertiary Care United States Center

被引：0

作者：

Heckert, Jason ^{[1
]}

Botterbusch, Samuel ^{[2
]}

Kipnis, Sarit ^{[1
]}

Bennet, Bonita ^{[3
]}

Creamer, Caroline ^{[3
]}

Alderson, Alice ^{[3
]}

Eads, Jennifer ^{[3
]}

Soulen, Michael ^{[3
]}

Pryma, Daniel ^{[3
]}

Mankoff, David ^{[3
]}

Metz, David ^{[3
]}

Katona, Bryson ^{[3
]}

机构：

[1] Hosp Univ Penn, 3400 Spruce St, Philadelphia, PA 19104 USA

[2] Univ Penn, Philadelphia, PA 19104 USA

[3] Perelman Sch Med, Philadelphia, PA USA

来源：

PANCREAS | 2020年 / 49卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：470 / 471

页数：2

共 50 条

[1] INITIAL EXPERIENCE WITH PEPTIDE RECEPTOR RADIONUCLIDE THERAPY (PRRT) FOR THE TREATMENT OF NEUROENDOCRINE TUMOR (NET) AT A TERTIARY CARE UNITED STATES CENTER.
Heckert, Jason
Eads, Jennifer
Soulen, Michael C.
Pryma, Daniel
Mankoff, David
Metz, David C.
Katona, Bryson W.
GASTROENTEROLOGY, 2019, 156 (06) : S370 - S370
[2] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs): A United States Experience
Katona, Bryson
Riff, Brian
Soulen, Michael
Pryma, Daniel
Bennett, Bonita
Wild, Damian
Nicolas, Guillaume
Teitelbaum, Ursina
Metz, David
PANCREAS, 2017, 46 (03) : 439 - 439
[3] Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Tumors (NETs) in a United States (US) Population
Katona, Bryson W.
Riff, Brian P.
Soulen, Michael C.
Pryma, Daniel A.
Bennett, Bonita J.
Wild, Damian
Nicolas, Guillaume
Teitelbaum, Ursina R.
Metz, David C.
GASTROENTEROLOGY, 2016, 150 (04) : S208 - S209
[4] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
Opalinska, M.
Sowa-Staszczak, A.
Grochowska, A.
Zwinczewska, H.
Hubalewska-Dydejczyk, A.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
[5] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
Duan, Heying
Girod, Bradley
Ninatti, Gaia
Ferri, Valentina
Kunz, Pamela
Fisher, George
Moradi, Farshad
Davidzon, Guido
Franc, Benjamin
Iagaru, Andrei
Aparici, Carina Mari
JOURNAL OF NUCLEAR MEDICINE, 2020, 61
[6] A single institution experience with peptide receptor radionuclide therapy (PRRT) in non-midgut neuroendocrine tumors (NETs)
Duan, H.
Ferri, V
Fisher, G.
Shaheen, S.
Davidzon, G.
Moradi, F.
Nguyen, J.
Franc, B.
Iagaru, A.
Mari, Aparici C.
JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 181 - 181
[7] Outcomes of peptide receptor radionuclide therapy (PRRT) in metastatic grade 3 neuroendocrine tumors (NETs).
Lung, Mei Sim
Hofman, Michael
Kong, Grace
Thang, Sue-Ping
Michael, Michael
Hicks, Rodney J.
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[8] Single Institution Experience with Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
Duan, H.
Ninatti, G.
Girod, B.
Ferri, V
Guja, K.
Song, H.
Kunz, P.
Fisher, G.
Lagaru, A.
Mari, Aparici C.
NEUROENDOCRINOLOGY, 2020, 110 : 253 - 253
[9] Single institution experience with peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET)
Duan, Heying
Ninatti, Gaia
Girod, Bradley
Ferri, Valentina
Kunz, Pamela L.
Fisher, George A.
Moradi, Farshad
Davidzon, Guido Alejandro
Franc, Benjamin Lewis
Iagaru, Andrei
Mari, Carina
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
[10] Single Institution Experience With Peptide Receptor Radionuclide Therapy (PRRT) in Neuroendocrine Tumors (NET)
Duan, H.
Ferri, V.
Kunz, P.
Davidzon, G.
Nguyen, J.
Moradi, F.
Franc, B.
Iagaru, A.
Aparici, C. Mari
PANCREAS, 2021, 50 (03) : 456 - 456

← 1 2 3 4 5 →